Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Hepatology. 2023 Feb 22;78(2):578–591. doi: 10.1097/HEP.0000000000000313

Table 2.

Prevalence of different cut offs of LSM in patients with fatty liver (CAP ≥263 dB/m)

Fibrosis severity by LSM cut-offs (kPa) FLD
(Total)
N = 173
NAFLD
(AUDIT <8)
N = 158
AFLD
(AUDIT≥8)
N = 15
≥5.6 kPa
(95% CI)
94 (54.3%)
(46%-62%)
85 (53.8%)
(46%-62%)
9 (60%)
(32%-84%)
≥6.5 kPa
(95% CI)
60 (34.7%)
(28%-42%)
56 (35.4%)
(28%-43%)
4 (26.7%)
(8%-55%)
≥7.1 kPa
(95% CI)
49 (28.3%)
(22%-36%)
46 (29.1%)
(22%-37%)
3 (20%)
(4%-48%)
≥8.6 kPa
(95% CI)
29 (16.8%)
(12%-23%)
27 (17.1%)
(12%-24%)
2 (13.3%)
(2%-41%)
≥12.1 kPa
(95% CI)
11 (6.4%)
(3%-11%)
10 (6.3%)
(3%-11%)
1 (6.7%)
(1%-32%)
≥13.1 kPa
(95% CI)
9 (5.2%)
(2%-10%)
9 (5.7%)
(3%-11%)
0
<8kPa
(95% CI)
138 (79.8%)
(73%-86%)
125 (79.1%)
(72%-85%)
13 (86.7%)
(60%-98%)
8-12 kPa
(95% CI)
24 (13.9%)
(9%-20%)
23 (14.6%)
(10%-21%)
1 (6.7%)
(1%-32%)
> 12kPa
(95% CI)
11 (6.4%)
(3%-11%)
10 (6.3%)
(3%-11%)
1 (6.7%)
(1%-32%)
FIB4 cutoffs
<1.63
(95% CI)
145 (83.8%)
(78%-89%)
133 (84.2%)
(78%-90%)
12 (80%)
(52%-96%)
1.63-2.67
(95% CI)
23 (13.3%)
(9%-19%)
20 (12.7%)
(8%-19%)
3 (20%)
(4%-48%)
>2.67
(95% CI)
5 (2.9%)
(1%-7%)
5 (3.2%)
(1%-7%)
0